GlassScript(P77) Azurion 7 M20
Payments companies reported to CMS as associated with (P77) Azurion 7 M20. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (P77) Azurion 7 M20, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (P77) Azurion 7 M20
These are the largest totals companies reported as associated with (P77) Azurion 7 M20. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Zahid Amin | Orlando, FL | Interventional Cardiology | $420.36 |
| Darryn Shaff | Allentown, PA | Vascular & Interventional Radiology | $413.61 |
| Gaurav Jindal | Atlanta, GA | Neuroradiology | $404.90 |
| John Streitman | Little Rock, AR | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $370.97 |
| Irina Goncharova | Milwaukee, WI | Vascular Surgery | $302.98 |
| Jess Oren | Danville, PA | Cardiovascular Disease | $254.48 |
| Abdulghani Saadi | Zephyrhills, FL | Interventional Cardiology | $149.49 |
| Lucas Cusumano | Los Angeles, CA | Diagnostic Radiology | $140.23 |
| Justin Mcwilliams | Los Angeles, CA | Vascular & Interventional Radiology | $140.22 |
| Samer Abbas | East Chicago, IN | Interventional Cardiology | $121.86 |
Prescribed (P77) Azurion 7 M20?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.